This Hedge Fund Can Still Deliver Double Digit Returns: Here Are Its Top Picks
Tamarack Capital Management was founded by Justin John Ferayorni, who remained the fund’s Chief Investment Officer and Portfolio Manager. Mr. Ferayorni holds A.B.
Hedge Fund - Tamarack Capital Management
Get Email AlertsJustin John Ferayorni Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Tamarack Capital Management |
| Manager | Justin John Ferayorni |
| Portfolio Value | $2,120,279 |
| Change This QTR | +0.01% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | STRM | 328,725.46,666,667 | $2,120,279 | 100% | |||
| 2. | Viatris IncCALL | VTRS | 0 | $0 | 0% | ||
| 3. | VTRS | 0 | $0 | 0% | |||
| 4. | MDRX | 0 | $0 | 0% | |||
| 5. | Veradigm Inc.CALL | MDRX | 0 | $0 | 0% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2022-12-01 | ||||
| 2021-03-23 | ||||
| 2021-02-16 | ||||
| 2020-02-14 | ||||
| 2020-02-14 |
News, Interviews and Investor Letters
Tamarack Capital Management’s Return, AUM, and Holdings
Tamarack Capital Management is a hedge fund that was founded by Mr. Justin John Ferayorni, its current Chief Investment Officer and Portfolio Manager. Before deciding to start his own firm, Mr.
Tamarack Capital Management's Ariad Pharmaceuticals, Inc. (ARIA) Holding Carries It To Strong Q3 Gains
Our data culled from the 659 funds in our database which filed 13Fs for the June quarter, and whose portfolios contained at least 5 long positions in companies valued at $1 billion, revealed some startling...
Medical Device Makers Top Tamarack Capital's Portfolio
Justin John Ferayorni’s Tamarack Capital has released its 13F filing for the reporting period of June 30.
Endologix, Inc. (ELGX), Quest Diagnostics Inc (DGX), The Spectranetics Corporation (SPNC), and More: Tamarack Capital’s Top Picks
Justin John Ferayorni’s Tamarack Capital Management has filed their latest 13F with the US Securities and Exchange Commission, revealing their long equity positions as of December 31 of last year.
Justin Ferayorni's Tamarack Capital Management Reports Increase of Passive Stake In This Stock
In a new filing with the Securities and Exchange Commission, Justin John Ferayorni's Tamarack Capital Management reported raising its passive stake in Endologix, Inc. (NASDAQ:ELGX).
